- Home
- RDI vs SRTS Comparison
RDI vs SRTS Comparison
Compare RDI & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDI | SRTS |
|---|---|---|
| Founded | 1937 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.0M | 45.6M |
| IPO Year | 1994 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RDI | SRTS |
|---|---|---|
| Price | $1.73 | $2.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 22.1K | ★ 519.7K |
| Earning Date | 11-17-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.76 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $202,988,000.00 | $27,482,000.00 |
| Revenue This Year | $15.10 | N/A |
| Revenue Next Year | $4.04 | $41.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.94 | $2.66 |
| 52 Week High | $2.41 | $5.49 |
Technical Indicators
Market Signals| Indicator | RDI | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 46.13 | 45.08 |
| Support Level | $1.69 | N/A |
| Resistance Level | $2.13 | $3.21 |
| Average True Range (ATR) | 0.12 | 0.40 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 48.09 | 4.67 |
Price Performance
Historical ComparisonAbout RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.